Call us Toll-Free

Weitz & Luxenberg Facebook Weitz & Luxenberg Google Weitz & Luxenberg Twitter Weitz & Luxenberg LinkedIn
English En Français


First Name
Last Name
Home Phone
Work Phone
City and State
Were you diagnosed with Asbestosis? Yes
Were you diagnosed with lung cancer? Yes
Were you diagnosed with Mesothelioma? yes
What is your date of diagnosis?
Additional Comments
Best time to call?

A new chemotherapy drug combination – Docetaxel plus Gemcitabine – showed "promising results" in treating mesothelioma, says new study

New chemotherapy treatment for mesothelioma: Docetaxel plus Gemcitabine.

The attorneys at the personal injury law firm of Weitz & Luxenberg have decades of experience defending victims’ rights in practice areas that include: accidents/general injury, dangerous drugs, medical malpractice, and environmental pollutants.


August 14, 2009 - A recent study performed at the Athens University School of Medicine in Greece reports that a new chemotherapy drug combination – gemcitabine plus docetaxel – offers “a promising first-line therapy for patients with mesothelioma cancer.”

According to the study, researchers enrolled 25 patients with malignant pleural mesothelioma. Each received 80 mg/m of docetaxel and 1,000 mg/m of gemcitabine on days 1 and 14 of a 28-day cycle.

The new mesothelioma treatment was scheduled for a maximum of six cycles, or until the mesothelioma spread, or there was too much toxicity for the patients.

The reason for the study, according to the authors, was that this combination – gemcitabine plus docetaxel – has not been investigated in mesothelioma before.

Docetaxel plus Gemcitabine

A total of seven out of the 25 patients (28 percent) responded to treatment, which means that for these seven patients their tumors decreased in size.

In 14 patients (56 percent), the disease remained stable (did not grow or regress), while in four (16 percent) their cancers became worse. The overall survival ranged from 12.4-17.5 months with a median survival of 15 months.

Although these results were not too impressive, the authors concluded that: “the administration of gemcitabine and doctaxel appears to be a promising first-line therapy for patients with mesothelioma, as it is well tolerated and appears to improve survival.”

Docetaxel plus Gemcitabine

Docetaxel (marketed under the name Taxotere) is an anti-mitotic chemotherapy used mainly for the treatment of breast, ovarian, and non-small cell lung cancer. Gemcitabine (marketed as Gemzar) is used in various cancers including: non-small cell lung cancer, pancreatic cancer, bladder cancer and breast cancer.

The standard chemotherapy treatment for malignant pleural mesothelioma is cisplatin and pemetrexed. Another chemo regimen used in the United States and other countries is the combination of cisplatin and gemcitabine.

Weitz & Luxenberg, P.C.

The law firm of Weitz & Luxenberg has protected the legal rights of blue-collar workers since 1986. And in that time the firm's mesothelioma lawyers have won several billion dollars in verdicts and settlements for clients injured by job-related asbestos exposure.

If you have been diagnosed with mesothelioma, and seek FREE legal guidance and answers to your concerns, please notify us through the communication form on this page. We will pursue your claim with vigilance to help you pay for medical bills, future and past lost wages, and suffering.

Please know, the firm works on a contingency basis, so there is no cost to you until we win a settlement or a verdict.

Mesothelioma Mesothelioma Home Page
head Mesothelioma: An Overview
kleio The Clock Is Ticking
asbestos Our Toughest Cases
Diagnosis Diagnosis
treatment Symptoms, Stages, Treatment
kleio Latest News
New York Numbers
Mesothelioma couple Real Stories

For legal help anywhere in the U.S. call:

1 - 800 - 476 - 6070

Prior results do not guarantee a similar outcome.


Mesothelioma Lawyer

Asbestos Lawyer

Mesothelioma Treatments

Mesothelioma Treatment

Mesothelioma Diagnosis

Mesothelioma Treatment

View Stats